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Sera of patients with SLE almost invariably contain antinuclear antibodies (1),
and frequently contain circulating immune complexes as well (2-5). Cryoglobu-
lins are one type ofimmune complex (6) that can be isolated from these sera. In
some instances, the cryoglobulins have been found to contain antinuclear anti-
bodies (7-9). For example, anti-DNA antibodies are selectively concentrated in
cryoglobulins isolated from some lupus patients' sera (9), and are also sometimes
found in patients' glomerular immune deposits (7, 8, 10). The presence of the
corresponding cellular antigens (e. g., DNA) in cryoglobulins or glomerular
eluates remains controversial, however (4, 5, 9, I1-14) . Although in certain
situations classical antigens have been described (9, 13, 14), in many instances
the only detectable components of these immune complexes have been self-
associatingIg (4, 5, 12). Immune complexes consisting ofIgboundtorheumatoid
factor, anti-F(ab')2, and antiidiotype have been shown previously in SLE, as well
as in other disorders (11, 15-19). The suggestion that certain autoantibodies
might arise through an antiidiotypic route (20) led us to examine the possibility
that immune complexes consisting of antinuclear antibodies and their antiidi-
otypes might be formed in SLE. We previously saw (21) that autoantibodies to a
cellular DNA-bindingprotein complex (p70/p80) and to DNA frequently coexist
in sera ofpatients with SLE. In the present study, we analyze the composition of
the cryoglobulins found in many of these sera. The results suggest that anti-
p70/p80 and anti-DNA antibodies can interact with one another, possibly by an
idiotype-antiidiotype-like mechanism.
Materials and Methods
Patients.
￿
Sera were obtained from patients diagnosed and treated at The Rockefeller
University Hospital, Patients met accepted criteria for the classification of SLE, mixed
connective tissue disease (MCTD),' or progressive systemic sclerosis (PSS) (22-24).
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Serologic Evaluation.
￿
Antibodies to p70/p80 were quantitated by ELISA, and their
presence wasconfirmed by immunoprecipitation of p70 and p80 (see below and reference
21). Antibodies to single- and double-stranded DNA (ssDNA and dsDNA) were quanti-
tated by RIA (25) and ELISA (26). Rheumatoid factor was measured by latex fixation
and ELISA using rabbit gamma globulin as coating antigen (27).
Isolation ofCryoglobulins.
￿
Cryoprecipitates were isolated by centrifugation of patients'
ice cold sera at 8,740 g for 15 min; the pellets were washed with ice-cold PBS, pH 7.5,
and then with distilled water, as described (9). Each cryoprecipitate was resolubilized in
0.5 ml of PBS with agitation for 1 h at 37°C, and was centrifuged at 8,740g for 5 min to
remove insoluble material. Purity of the isolated cryoglobulins was monitored by electro-
phoresis on 12.5% SDS-polyacrylamide gels (28) using purified myeloma proteins as
standards.
Immunoprecipitation of Radiolabeled p70lp80.
￿
K562 cells were metabolically labeled
with [asS]methionine as previously described (21). Washed cells were lysed by sonication
in ice-cold 150 mM NaCl, 50 mM Tris pH 7.5, 2 mM EDTA, 0.5 mM PMSF, 5 mM
iodoacetamide, and were then centrifuged at 8,740 g for 5 min. Aliquots of the cleared
extract were immunoprecipitated for 1 h at 37°C with either 10 ul of cryoglobulin-
depleted serum (see above), or 10 wl of the isolated, resolubilized cryoprecipitate. The
immunoprecipitates were adsorbed to protein A-Sepharose 4B (Pharmacia Fine Chemi-
cals, Piscataway, NJ) for 90 min at 37°C, and radioactive proteins were eluted from the
beads by boilingin sample buffer, followed by analysis on 12.5% SDS-polyacrylamide gels
(21) and fluorography (29).
Detection ofAutoantibodies in Cryoprecipitates.
￿
Isolated cryoprecipitates were resolubil-
ized as above, and tested for reactivity with variousantigens by ELISA at 37'C. Antibodies
to ss and dsDNA were measured by ELISA using microtiter plates (Costar, Cambridge,
MA) coated with ssDNA or dsDNA from calf thymus (Sigma Chemical Company, St.
Louis, MO), respectively (26). Anti-p70/p80 antibodies in the isolated cryoprecipitates
were quantitated by ELISA using microtiter plates coated with anti-p70/p80 mAb 162-
11 (21). We obtained crude p70/p80 antigen by adsorbing K562 cell lysate on DEAF
cellulose, and eluting with 0.3 M NaCI; the eluted p70/p80 proteins were then immuno-
purified by binding to the mAb-coated wells for 2 h at 22 °C. We removed cellular DNA
bound to p70/p80 by washing the antigen-coated wells for 30 min with 0.5 M NaCl, 20
mM Tris (pH 7.5), 2 mM EDTA (30). Diluted test samples were added to the wells for 2
h at 37 °C, followed by peroxidase-conjugated goat anti-human -Y or k chain antibodies
(Tago Inc., Burlingame, CA) for I h at 37 °C. Substrate was added and OD was read at
492 nm.
Assayfor p70lp80 Antigen in Cryoprecipitates.
￿
p70/p80 antigen in the isolated, resolu-
bilized cryoprecipitates was detected by ELISA (21). Microtiter plates were coated with
162-11 antibodies as above, followed by the addition of diluted cryoprecipitate for 2 h at
37°C . The binding of alkaline phosphatase-conjugated 111-12 (an mAb that binds to a
different epitope of p70/p80 than does 162-11) was then measured.
Adsorption ofSera on DNA-Cellulose.
￿
0.5 ml ofpatient CK serum (containing both anti-
p70/p80 and anti-DNA antibodies) was dialyzed against PBS (pH 7.2) and adsorbed on a
column of dsDNA cellulose (1 .0 gdry powder from Sigma Chemical Co. in PBS) for 1 h.
Unbound Ig was collected, and the column was washed extensively with PBS. Some of
the bound anti-DNA antibodies were eluted with 0.5 M NaCI, 20 mM sodium phosphate
buffer (pH 7.2). The eluate was dialyzed against PBS, and both eluate and effluent
fractionswere tested by ELISA foranti-p70/p80 antibodies, anti-dsDNA,andanti-ssDNA
antibodies, and total Ig (31). The specific activity of either anti-p70/p80 or anti-DNA in
the fractions was calculated as follows: (specific antibody in fraction X total antibody in
serum)/(total antibody in fraction X specific antibody in serum).
Inhibition of Anti-p70/p80 Binding by anti-DNA mAbs.
￿
Microtiter plates were coated
with either 162-11 or 1 11-12 purified mAbs at 10 kg/ml, incubated with p70/p80 antigen,
and washed with 0.5 M NaCl to remove bound DNA as above. Sera containing anti-
p70/p80 antibodies were diluted 1:10,000 in culture medium containing -1 jag/ml of
human IgM anti-DNA mAb or human IgM mAb without DNA reactivity. Anti-DNARheu-
matoid
factor
* Reciprocal titer (ELISA).
$ RIA.
0 By latex fixation and ELISA.
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TABLE I
mAbs tested included W 1, W4, W8, W18, W48, W64, and W94 (obtained by immortali-
zation of peripheral blood B cells from a patient with SLE, high levels of serum anti-DNA
antibodies, and trace amounts of serum anti-p70/p80 antibodies) (32); J2, J3, J7, and J8
(from a patient with MCTD, low levels of anti-DNA antibodies, and 1 :6,250 titer of anti-
p70/p80 antibodies, reference 31); M3 (from a normal volunteer with a family history of
SLE); and 15/14, 16/6, and 18/2 (a generous gift from Drs. Blair Ardman and Robert
Schwartz, Hematology/Oncology Division, Department of Medicine, Tufts New England
Medical Center, Boston, MA) (33). Irrelevant control antibodies were D3A (IgM), AC
(IgM), EG5.1 (IgE, IgM), and U266 (IgE). Each mAb was preincubated with diluted
serum for 30 min at 22 °C before adding 100 ul to each antigen-coated well for 2 h at
22'C . The wells were washed and then incubated for 90 min with 100 Al of 1 :1,500
peroxidase-conjugated goat anti-human L chain antibodies (a and a specificities, from
Tago Inc.). After another washing, aminoantipyrine-phenol substrate was added and
absorbance read at 492 nm. Binding was compared with a standard curve generated by
different amounts of serum diluted in blocking medium.
We performed similar inhibition experiments using alkaline phosphatase-conjugated
162-11 or 111-12 mAbs; for each conjugated mAb, the microtiter plate was coated with
antigen using the other (unconjugated) mAb as described (21). The conjugated mAbs
were used at a final dilution of 1 :100 in culture medium alone or culture medium
containing ^-1 Ag/ml of human IgM mAb exactly as described above. The wells were
washed, p-nitrophenyl phosphate substrate was added, and absorbance measured at 405
nm.
Results
Serologic Evaluation.
￿
We analyzed sera from six patients with connective tissue
disorders that contained anti-p70/p80 antibodies (Table 1) . By standard clinical
criteria (22-24), four of these patients had SLE, one had MCTD, and one had
PSS. The titers of anti-p70/p80 antibodies in the patients' sera ranged from
1 :250 to >1 :15,000,000 as measured by enzyme immunoassay. Sera from each
patient with SLE and from the patient with MCTD contained high levels of
antibodies to ssDNA and dsDNA, as well as cryoglobulins. In contrast, serum
from patient JK with PSS contained anti-p70/p80 antibodies at a titer of
1 :156,000, but no anti-DNA antibodies or cryoglobulins. None of the sera
contained IgM or IgG rheumatoid factors, as determined by latex fixation or
ELISA (Table I) .
Isolation of Cryoglobulins.
￿
Since cryoglobulins represent a type of circulating
Serologic Characteristics ofPatients
Patient Diagnosis Anti-p70/p80* Anti-ssDNA$ Anti-dsDNAt Cr
globo
-
ulin
CK SLE >15,000,000 96.9 94.0 +
DJ SLE 156,250 77 .3 66.5 +
AT SLE 250 58.5 64.8 +
LG SLE 250 97 .6 100 .0 +
JM MCTD 3,906,250 40.7 23 .7 +
JK PSS 156,250 3 .8 2.6 -1032
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FIGURE 1 .
￿
Gel analysis of isolated cryoglobulins. Cryoglobulins were isolated from patient
CK andJM sera ; 0.1 ul ofserum after removal of the cryoprecipitate(CK SerumandJM Serum,
respectively), 5.0,ul of CK cryoprecipitate in PBS (CK Cryo) and 10 A1 ofJM cryoprecipitate in
PBS(JM Cryo) were analyzed by electrophoresis on a 12.5% SDS-polyacrylamide gel . Proteins
were visualized by staining the gel with Coomassie Blue R-250 . Purified myeloma proteins
(6.0 Wg/lane ofIgM is or IgG K, respectively) were also analyzed on thesame gel for comparison .
The positions of 1 and 7 heavy chains and L chain are indicated . Arrow indicates serum
albumin .
immune complex (6, 9), it was of interest to examine the composition of the
cryoglobulins found in these sera. Cryoglobulins were isolated from four of the
sera shown in Table I (patients CK, AT, LG, and JM). Because cryoglobulins
can contain trapped extraneous serum proteins, the purity of the isolated,
redissolved cryoglobulins was determined by SDS-PAGE under reducing condi-
tions (Fig . 1) . The relative amounts of human serum albumin in each isolated
cryoglobulin, compared with those of cryoglobulin-depleted serum, were taken
as an index of purity (i .e ., lack of nonspecific trapping) . After removal of the
cryoprecipitate, serum from patientCK (CK Serum) contained a prominent band
corresponding to the mobility of human serum albumin (arrow), as well as less
prominent bands comigrating with A and yH chainsand K L chains . The isolated
cryoglobulin (CK Cryo) contained A . and y H chains in approximately equal
amounts, as well as L chains, but only traces ofserum albumin . p70/p80 antigen
was not detectable in the cryoprecipitates by Coomassie blue staining . We
obtained similar results using the cryoglobulin-depleted serum (JM Serum) and
isolated cryoglobulin (JM Cryo) from patient JM . Cryoglobulins from patients
AT and LG were of comparable purity and also contained mainly IgG and IgMREEVES AND CHIORAZZI
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FIGURE 2 . Immunoprecipitation of ['SS]methionine-labeled cell lysate using isolated cry-
oglobulins or serum depleted of cryoprecipitate . K562 erythroleukemia cells were labeled for
12 h with ["S]methionine and a cell lysate was immunoprecipitated at 37°C with 10 Al of
normal human serum(NHS), CK serum after removal of the cryoprecipitate (CK Serum-Cryo),
CK-isolated cryoprecipitate (CK Isol. Cryo),JM serum after removal of the cryoprecipitate (IM
Serum-Cryo), orJM isolated cryoprecipitate (JM Isol. Cryo) . Immunoprecipitates were adsorbed
to protein A-Sepharose, eluted by boiling in sample buffer, and analyzed on a 12.5% SDS-
polyacrylamide gel . Immunoprecipitated proteins were detected by fluorography . Positions of
proteins A, B, B', C, D, E, F, andG characteristically immunoprecipitated by anti-Sm orRNP
antibodies are indicated . The positions of p70 and p80 are indicated by arrows.
(not shown) . The pattern obtained with purified myeloma proteins is shown for
comparison (lane 1, IgM «; lane 2, IgG rc) . By comparing the amount of serum
albumin trapped in the isolated cryoglobulins with that in serial dilutions of
cryoglobulin-depleted serum, the concentration of serum albumin in the serum
was found to be at least 1,250 times that contained in each of the four isolated
cryoglobulins (i.e ., that the extent of nonspecific trapping of serum proteins in
the isolated cryoprecipitate was <0 .1%) .
Composition of the Isolated Cryoglobulins .
￿
To examine the specificities of the
Ig constituents of the cryoprecipitates, the isolated warmed cryoglobulins were
used to immunoprecipitate radioactively labeled cellular proteins (Fig . 2) . We
saw a strikingly different pattern of immunoprecipitated [sSS]methionine-labeled
proteins with patients CK andJM cryoglobulin-depleted sera than that seen with
their isolated cryoglobulins . CK cryoglobulin-depleted serum (CK Serum-Cryo)
immunoprecipitated prominent bands A, B, B', C, D, E, F, and G, consistent
with the presence of anti-Sm and antiribonucleoprotein (RNP) antibodies in this
serum, but very little p70/p80. In contrast, the isolated cryoglobulin (CK Cryo)1034
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TABLE II
Relative Amounts ofAntibodies in Isolated Cryoglobulins
0
*
* p70/p80 antigen (ELISA OD units).
$ Quantity of antibody too small to permit calculation.
immunoprecipitated prominent bands ofM, ^-70,000 and 80,000 (arrows), which
typify anti-p70/p8O reactivity. Notably, the isolated cryoglobulin immunoprecip-
itated only traces ofthe small nuclear ribonuclear proteins A, B, B', C, D, E, F,
and G(compare CK Isol. Cryo with CK Serum-Cryo) . Similar results were obtained
with the cryoglobulin-depleted serum and the isolated cryoglobulin of patient
JM. In this case, the cryoglobulin-depleted serum (JM Serum-Cryo) immunopre-
cipitated prominent bands A-G because of the presence of >1:10' titer of anti-
RNP antibodies in this serum; p70/p8O also appeared in this immunoprecipitate.
In contrast, the isolated cryoglobulin (JM Isol. Cryo) immunoprecipitated prom-
inent p70/p8O bands, but only traces ofbands A-G. The pattern obtained using
normal human serum (NHS) is shown for comparison.
The amounts of serum autoantibodies in the isolated cryoglobulins were also
assessed by ELISA (Table II). For each serum, we determined the enrichment
of specific autoantibodies relative to the amount of nonspecific trapping of
albumin. Anti-p70/p8O antibodies were enriched in each of the four isolated
cryoglobulins, and anti-DNA antibodies were enriched in three of the four.
Because of low levels ofanti-DNA antibodies inJM serum (Table I), it could not
accurately be determined whether these antibodies were enriched in the cry-
oglobulin. IgM anti-p70/p8O and anti-DNA antibodies predominated over IgG
in each cryoprecipitate. Anti-Sm and RNP antibodies (patient CK) and anti-RNP
antibodies (patientJM) were not enriched in the isolated cryoglobulins (data not
shown). Using a highly sensitive and specific ELISA, p70/p8O antigen was
detectable in the cryoprecipitate from patient AT, and in lesser quantities in the
other three isolated cryoglobulins.
Anti-p70/p80 and Anti-DNA Antibodies Are Distinct Immunoglobulin Popula-
tions. Since certain anti-DNA antibodies also can bind nuclear proteins such as
the Sm antigen (34), we tested thepossibility that theanti-DNA and anti-p70/p8O
reactivities in these patients' sera and cryoprecipitates might be due to the same
antibodies. We warmed CK serum containing cryoglobulin to 37'C and adsorbed
it on dsDNA-cellulose; the effluent and 0.5 M NaCl eluate were collected
separately (Table III). The column effluent contained anti-p70/p8O activity, but
only traces of anti-DNA activity. The eluate contained anti-DNA antibodies at
-100-fold increased specific activity, but no anti-p70/p8O antibodies. Thus, the
anti-p70/p8O and anti-DNA antibodies in this serum are distinct Ig populations.
Binding ofAnti-p70/p80 Antibodies to Antigen Is Blocked by Anti-DNA mAbs.
￿
The
above experiments suggested that the cryoglobulins present in these sera contain
Anti-p70/p80 Anti-dsDNA Anti-ssDNA
Patient p70/p
IgG IgM IgG IgM IgG IgM antige
CK 5 125 25 45 ND$ 40 0.10
JM 2 5 ND ND ND ND 0.02
AT ND 50 ND ND ND 19 0.30
LG 10 250 1 192 1 83 0.07REEVES AND CHIORAZZI
TABLE III
Anti-p70/p80 Antibodies Can Be Separatedfrom Anti-DNA Antibodies by
Adsorption on dsDNA-cellulose
* Absorbance at 492 nm (ELISA).
Eluate obtained with 500 mM NaCl.
§ Calculated as: (specific antibody in fraction X total antibody in serum)/(total
antibody in fraction X specific antibody in serum).
Background activity.
CULTURE IVIED
AC OgMI
D3A(IgM,IgD)
ANTI-DNA (18/2)
ANTI-DNA (W8)
ANTI-DNA (W94)
ANTI-DNA (W48)
%BINDING TO P70/P80
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FIGURE 3.
￿
Inhibition ofJM serum bindingto p70/p8O by human anti-DNA mAbs. Microtiter
plates were coated with p70/p8O antigen by adsorption to mAb 162-11; the binding ofJM
anti-p70/p8O antibodies to antigen was measured by ELISA in the presence or absence of
human IgM mAbs at a final concentration of -1 jig/ml. Binding in the presence of inhibitors
is expressed as percent of control binding to p70/p8O as determined by comparison with a
standard curve ofJM serum binding to p70/p8O in the absence of inhibitors. Control mAbs
without anti-DNA reactivity were AC (IgM), and D3A (IgM plus IgD); IgM anti-DNA
antibodies tested included 18/2, W8, W94, and W48. SE is indicated.
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at least three components: anti-p70/p80 antibodies, anti-DNA antibodies, and
small amounts of p70/p80 antigen (in at least some instances). Although both
anti-p70/p80 and anti-DNA antibodies would bind to the complex of p70/p80
and DNA, the antigen was only a minor component of the cryoglobulin, as
determined by SDS-PAGE (Fig. 1) and ELISA (Table II). We therefore examined
the possibility that the Ig components of the cryoglobulins might self-associate .
Since rheumatoid factor activity was undetectable by ELISA and latex fixation
assays in either the isolated cryoglobulins or the sera, weexamined the possibility
that anti-DNA and anti-p70/p80 antibodies might interact at their antigen-
combining sites. Because of the relatively small amounts of purified cryoprecip-
itate obtainable from the patients' sera, we used an inhibition assay to determine
whether human anti-DNA mAbs (32, 33) could inhibit the binding of anti-
p70/p80 antibodies to p70/p80 antigen. 1 of 15 anti-DNA mAbstested inhibited
binding of JM anti-p70/p80 antibodies to p70/p80 antigen by -50% (Fig. 3,
anti-DNA 18/2). Lesser inhibition was displayed by others (e. g., anti-DNA W8),
while others showed no inhibition. IgM mAbs that were not reactive with DNA
(AC and D3A) displayed no substantial inhibition of binding. The anti-DNA
Antibody
Serum before
adsorption
(A492)*
Effluent
A492* Sp actl
Eluatet
A492* Sp act$
Anti-p70/p8O 0.93 0.47 0.63 0.011 0
Anti-ssDNA >2.0 0.05 0.11 0.25 110
Anti-dsDNA 0.89 0.041 0.0 0.08 63
Total IgG 0.97 0.92 - 0.101036 INTERACTION BETWEEN TWO AUTOANTIBODIES IN LUPUS
CULTURE IVIED [2
D3A (IgM,IgD)
AC (IgM)
ANTI-DNA (W4)
ANTI-DNA (W94)
ANTI-DNA (W4B)
ANTI-DNA (W8)
MONOCLONAL
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03A (IgM,IgD)
AC (IgM)
ANTI-DNA (W4)
ANTI-DNA (W94)
ANTI-DNA (W4B)
ANTI-DNA (W8)
BINDING TO P70/P80
20 40 60 80 100
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H
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FIGURE 4.
￿
Inhibition of binding of murine mAbs to p70/p8O by human anti-DNA mAbs.
Forinhibition of 111-12 binding(top), microtiter plates were coated with 162-11 mAbfollowed
by p70/p8O antigen; for inhibition of 162-11 binding (bottom) plates were coated with 111-12
followed by p70/p8Oantigen. Antigenbindingof alkaline phosphatase-conjugated mAbs 111-
12 or 162-11, respectively, in thepresence or absence ofhumanIgM mAbs at a concentration
of ^-1 gg/ml was determined by ELISA. Binding in the presence of inhibitors is expressed as
percent control binding to p70/p8O as determined by comparison with standard curves of
alkaline phosphatase-conjugated 111-12 or 162-11 binding to p70/p8O in the absence of
inhibitors. Control mAbs without anti-DNA reactivity were AC (IgM) and D3A (IgM plus
IgD); IgManti-DNA antibodies tested included W4, W94, W48, and W8. SE is indicated.
mAbs alone displayed no binding to the p70/p80 antigen-coated wells, showing
that cellular DNA fragments bound to p70/p80 had been removed by the 0.5
M NaCl wash (see Materials and Methods), and that the monoclonal antibodies
had no cross-reactivity with p70/p8O.
Murine monoclonal anti-p70/p80 antibodies were also tested in the inhibition
ELISA. Monoclonal antibodies 111-12 and 162-11 were previously shown to
bind to distinct antigenicsitesofp70/p80 (21). The bindingof 111-12 top70/p80
was inhibited substantially by several monoclonal anti-DNA antibodies including
W4 and W94 (Fig. 4, top). Other anti-DNA mAbs inhibited less strongly or not
at all (Fig. 4, top, W48), while irrelevant IgM monoclonal antibodies AC and
D3A did not inhibit significantly. Neither the control IgM mAbs nor any of the
15 anti-DNA mAbs inhibited 162-11 binding to p70/p80 (Fig. 4, bottom).
Discussion
We have previously described autoantibodies that react with a DNA-binding
protein complex, consisting of ^-70,000 and ^80,000 dalton subunits, in sera
from patients with SLE, MCTD, and PSS (21). Recently, exchange of sera has
shown that this antigen is identical to the Ku antigen (35, 36). The present study
extends our previous observation that anti-p70/p80 antibodies are frequently
associated with high levels of serum anti-DNA antibodies in patients with SLE,REEVES AND CHIORAZZI
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and in some patients with MCTD, suggesting that in these patients, a macromo-
lecular complex consisting of the p70 and p80 proteins bound to DNA may be
a major target ofautoimmunity. Similarly, autoantibodies to several components
of macromolecular complexes involved in mRNA splicing frequently occur
together (37-40). The reasons for the linked production of autoantibodies to
different components of the same macromolecular assembly are not well under-
stood. One possibility is that a single autoantibody crossreacts with more than
one component ofthe complex. For instance, an mAb reactive with both the Sm
protein antigen and DNA has been described recently (34). This mechanism
cannot explain the linkage of anti-p70/p80 and anti-DNA antibodies in our
patients' sera, however, since the two autoantibody specificities can be separated
byadsorption on DNA-cellulose (Table III). Asecond possibility is thatantibodies
to a normally nonimmunogenic molecule, such as DNA, can arise due to an
association with an immunogenic protein. This mechanism has been proposed as
an explanationforthe observation that anti-DNA antibodies are produced during
the course ofimmunizing animals with RNA polymerase, another DNA-binding
protein (41). We cannot rule out a similar mechanism to explain the strong
association of anti-DNA antibodies with anti-p70/p80 antibodies. However,
another possibility is that certain linked autoantibodies are part of immune
networks (20, 42). For example, immunization of animals with BisQ, an acetyl-
choline analog, results in the production of anti-acetylcholine antibodies as well
as anti-antiacetylcholine antibodies, some of which react with the acetylcholine
receptor and induce a myasthenia gravis-like syndrome (43). Autoantibodies to
other cellular receptors can be induced as part of an antiidiotypic response to
antihormone antibodies (44, 45) or anti-viral antibodies (46). By analogy, DNA
might be considered tobe a receptor for DNA-binding proteins such as p70/p80;
our present study supports the notion that certain anti-p70/p80 antibodies might
be linked to anti-DNA antibodies through an autoimmune network.
In this study, the analysis of cryoglobulins (i. e., immune complexes, Table I)
found in the sera ofSLEpatients with anti-p70/p80 antibodies revealedaspecific
enrichment in anti-p70/p80 and anti-DNA antibodies, but not other autoanti-
bodies such as anti-Sm or anti-RNP (Fig. 2, Table I1). Although small amounts
of p70/p80 antigen were detectable in several of the isolated cryoprecipitates
(Table 1), the predominant components ofthe cryoglobulins were IgG and IgM
(Fig. 1), suggesting, as has been found with other isolated cryoglobulins (11, 47),
that the Ig may self-associate . This possibility was supported by the finding that
preincubation of the patients' anti-p70/p80 antibodies with human anti-DNA
mAbs inhibited their ability to bind antigen (Figs. 3 and 4). An interaction
between anti-p70/p80 and anti-DNA antibodies in the cryoglobulins is not likely
to be due to rheumatoid factor-like activity, since both the sera and the isolated
cryoprecipitates had no rheumatoid factor activity detectable by either latex
fixation or by ELISA (Table 1). In addition, the selectivity o£ antibodies in the
cryoprecipitates argues against a rheumatoid factor-like interaction. Since the
anti-DNA mAbsinhibited binding ofanti-p70/p80 antibodies to p70/p80 antigen
(Fig. 3), and since the anti-DNA mAbs do not bind to other Ig(32) or to p70/p80
antigen, the anti-DNA antibodies most likely interact with theantigen-combining
site of anti-p70/p80 antibodies. However, we have not yet determined if the1038
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p70/p8O antibodies bind to the antigen-combining site or a noncombining site
V region determinant of anti-DNA antibodies, i.e., whether the two species of
autoantibodies are homobodies or epibodies (48). Antibodies to hormones and
their antiidiotypes that react with hormone receptors (42, 48) are thought to be
examples of homobodies or internal images. In contrast to epibodies, homobodies
appear to share certain topographical features with antigen, and are thus fre-
quently not restricted to a specific individual or animal species (49). It is
noteworthy, therefore, that human anti-DNA antibodies inhibited antigen bind-
ing of other patients' anti-p70/p8O antibodies as well as a murine anti-p70/p8O
mAb (Fig. 4). If certain anti-p70/p8O and anti-DNA antibodies are, in fact,
homobodies, then it would be predicted that a population of autoantibodies
reactive with the DNA-binding site of p70/p8O exists in the sera and isolated
cryoglobulins of these patients . Preliminary studies suggest that this may be the
case (unpublished observation).
The association ofanti-DNA and anti-p70/p8O autoantibodies in these patients'
sera may be relevant to their immune complex disease. Immune complex for-
mation is a central feature of the network theory (50), and deposition of immune
complexes is thought to be an important aspect of immune injury in SLE (2, 7,
8). The present studies suggest that immune complexes consisting of anti-DNA
antibodies bound to the V regions of anti-p70/p8O antibodies occur in the sera
of some patients with SLE. Other anti-DNA antibodies that bind to the Fc
portion of Ig have also been described (51). The production of anti-DNA
antibodies as antiimmunoglobulins (reactive with either variable or constant
regions) might be one way of generating autoantibodies to a normally nonim-
munogenic substance, such as DNA. However, we cannot tell from these studies
how frequently such antibodies are encountered, or whether they are significant
in the pathogenesis of immune complex disease. In regard to the latter issue,
preliminary studies in our laboratory indicate that in one patient with SLE, a
sharp rise in anti-p70/p8O antibodies occurred just before a parallel rise in serum
anti-DNA antibodies and cryoglobulins, and a decline in complement levels and
worsening of lupus nephritis (52). It seems plausible that immune complexes
consisting of anti-p70/p8O and anti-DNA (idiotype-antiidiotype) might have
played a role in the patient's renal deterioration. Thus, the significance of anti-
DNA antibodies in SLE might be analogous, in some respects, to that of
rheumatoid factors in rheumatoid vasculitis, where immune complexes consisting
of Ig and rheumatoid factor are thought to play a significant pathogenic role
(53). In contrast to the patients with SLE, a patient with PSS and high serum
levels of anti-p70/p8O antibodies did not produce anti-DNA antibodies or cry-
oglobulins (Table I, patientJK), and maintained nearly constant levels of anti-
p70/p8O antibodies over time (unpublished observation). This is of particular
interest, since whereas American patients with anti-p70/p8O antibodies have
presented with a relatively broad spectrum of autoimmune disease, including
SLE, MCTD, and PSS (21, 36), Japanese patients have presented mainly with
PSS-polymyositis overlap syndrome (35) . It will be of interest to see whether the
different clinical presentation of the latter group of patients might reflect an
inability to generate a population of antibodies with dual Ig-DNA reactivity .Summary
We have previously shown that sera from some patients with SLE and related
disorders contain autoantibodies to a DNA-binding protein complex designated
p70/p8O. The present study shows that anti-p70/p8O autoantibodies are fre-
quently accompanied by anti-DNA antibodies and cryoglobulins. When the
cryoglobulins were isolated, they were found to be specifically enriched in both
anti-p70/p8O and anti-DNA activities. The anti-p70/p8O and anti-DNA antibod-
ies were found to be distinct populations of autoantibodies rather than a single
crossreactive species, since they could be separated from one another by chro-
matography on DNA-cellulose. Certain human anti-DNA mAbs could inhibit the
binding of autoimmune polyclonal anti-p70/p8O antibodies to p70/p8O, suggest-
ing that anti-DNA antibodies might also associate with the variable regions of
some anti-p70/p8O antibodies in the cryoglobulins. Binding of one murine anti-
p70/p8O mAb (111-12) also was inhibited by certain human anti-DNA mAbs,
but the binding of another murine mAb (162-11) to a different epitope of
p70/p8O was not. These studies suggest that certain anti-DNA antibodies may
interact with the variable regions of a population of anti-p70/p8O antibodies.
The cryoglobulins found in the sera containing both anti-p70/p8O and anti-DNA
antibodies may represent immune complexes consisting, in part, of idiotype and
antiidiotype.
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